The past year has seen the publication of several important findings regarding the epidemiology, molecular biology, and treatment of pediatric rhabdomyosarcoma and other childhood soft tissue sarcomas. These research advances will help us better understand the mechanisms involved in tumor development and progression, tailor therapy according to specific pretreatment tumor biologic characteristics, and develop novel treatments for rhabdomyosarcoma.
No takes yet. Share an insight, caveat, or question.
Alberto S. Pappo (1994) studied this question.